UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.762
AS - Asia 22.375
EU - Europa 10.165
SA - Sud America 1.515
AF - Africa 252
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 24
Totale 57.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.466
HK - Hong Kong 13.307
SG - Singapore 4.217
FI - Finlandia 4.165
CN - Cina 2.020
VN - Vietnam 1.267
UA - Ucraina 1.205
IT - Italia 1.169
BR - Brasile 1.128
DE - Germania 1.070
RU - Federazione Russa 761
IE - Irlanda 439
FR - Francia 390
KR - Corea 336
TR - Turchia 307
IN - India 265
GB - Regno Unito 211
SE - Svezia 194
ES - Italia 182
AR - Argentina 160
CA - Canada 134
BD - Bangladesh 109
AT - Austria 108
JP - Giappone 102
MX - Messico 89
IQ - Iraq 76
ZA - Sudafrica 75
NL - Olanda 60
PL - Polonia 58
PK - Pakistan 57
EC - Ecuador 54
ID - Indonesia 47
VE - Venezuela 44
CZ - Repubblica Ceca 43
CO - Colombia 41
MA - Marocco 35
UZ - Uzbekistan 34
SA - Arabia Saudita 31
CL - Cile 28
ET - Etiopia 28
EU - Europa 28
MY - Malesia 27
JO - Giordania 24
PY - Paraguay 24
EG - Egitto 23
PH - Filippine 21
KE - Kenya 20
AE - Emirati Arabi Uniti 19
LT - Lituania 18
TN - Tunisia 18
AU - Australia 17
PE - Perù 16
DO - Repubblica Dominicana 15
DZ - Algeria 14
KG - Kirghizistan 14
KZ - Kazakistan 12
HN - Honduras 11
CH - Svizzera 10
UY - Uruguay 10
CR - Costa Rica 9
PA - Panama 9
AL - Albania 8
OM - Oman 8
AZ - Azerbaigian 7
BE - Belgio 7
IL - Israele 7
AO - Angola 6
BO - Bolivia 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
NG - Nigeria 6
NP - Nepal 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
HR - Croazia 5
HU - Ungheria 5
JM - Giamaica 5
NI - Nicaragua 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BZ - Belize 4
GR - Grecia 4
GT - Guatemala 4
KW - Kuwait 4
LU - Lussemburgo 4
LY - Libia 4
MK - Macedonia 4
QA - Qatar 4
RO - Romania 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
CI - Costa d'Avorio 3
IR - Iran 3
PT - Portogallo 3
Totale 57.065
Salva come PNG Salva come JPEG
Città #
Hong Kong 13.273
Ann Arbor 4.703
Helsinki 3.835
Woodbridge 2.446
Singapore 2.142
San Jose 1.720
Jacksonville 1.462
Chandler 1.347
Houston 1.186
Princeton 1.164
Dallas 1.121
Wilmington 1.110
Ashburn 1.056
Munich 451
Council Bluffs 434
Dong Ket 422
Dublin 417
Beijing 360
Lauterbourg 345
Ho Chi Minh City 293
The Dalles 284
Andover 283
Nanjing 261
Izmir 248
Boardman 245
Moscow 219
Salerno 210
Hanoi 194
Los Angeles 173
Pellezzano 171
Düsseldorf 145
New York 137
Naples 134
São Paulo 121
Valencia 120
Fairfield 100
Nuremberg 95
Santa Clara 95
Shenyang 90
Changsha 86
Nanchang 86
Orem 86
Jiaxing 81
Tokyo 78
Hebei 77
Frankfurt am Main 69
Brooklyn 66
Chennai 66
Turku 62
Washington 57
Redwood City 55
Warsaw 54
Rome 53
London 49
Norwalk 48
Tianjin 48
Chicago 47
Montreal 47
Johannesburg 46
Vienna 45
Pune 42
Manchester 41
Rio de Janeiro 41
Seattle 40
Amsterdam 39
Dearborn 37
Phoenix 37
Brno 36
Da Nang 36
Napoli 36
Denver 35
Cambridge 34
Haiphong 34
Milan 34
San Francisco 34
Boston 32
Stockholm 32
Tashkent 32
Brasília 31
Columbus 31
Atlanta 29
Addis Ababa 28
Baghdad 28
San Diego 27
Belo Horizonte 26
Mumbai 26
Toronto 26
Guangzhou 25
Mexico City 25
Shanghai 24
Jinan 23
Lahore 23
Dhaka 22
Amman 21
Curitiba 21
Mestre 20
Quito 20
Biên Hòa 19
Hải Dương 19
Poplar 19
Totale 45.103
Salva come PNG Salva come JPEG
Nome #
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 2.032
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 1.979
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 905
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 891
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors 856
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 710
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 653
Endocrine disorders during the first year after autologous stem-cell transplant. 589
Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. 587
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 580
2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 513
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 491
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 481
Aplastic anemia: Pathophysiology 481
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 472
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia 469
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 416
Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review 371
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 368
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. 366
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 357
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 356
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 353
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 340
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 328
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 324
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 323
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 308
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 295
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 286
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 283
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 276
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells 269
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 246
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 222
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 215
The urokinase-receptor in infectious diseases. 210
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 205
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 202
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 198
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 195
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 194
CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples 194
A backwards evolution in a case of myeloproliferative disease 192
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 190
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 190
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 189
Interleukin-2 therapy in relapsed acute myelogenous leukemia. 188
Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes. 180
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 179
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 176
Unresponsiveness to erythropoietin therapy in a case of Blackfan Diamond anemia. 174
67 kDa laminin receptor: structure, function and role in cancer and infection. 174
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 174
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 173
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 173
Adjuvant treatment of diabetic foot 172
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 171
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 169
Role of the urokinase receptor in hematopoietic stem cell transplantation 165
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 164
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 162
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 162
Bendamustine in combination with rituximab for elderly patients with aggressive B non hodgkin lymphoma not eligible for anthracycline-based therapy 162
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 162
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 161
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 158
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 158
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 158
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 157
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 154
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 153
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 152
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 152
The role of FAS-mediated apoptosis in chronic myelogenous leukemia. 151
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 150
Discovery of new small molecules targeting the vitronectin binding site of the urokinase receptor that block normal and leukemic cell migration 149
High dose rHuEPO may induce complete remission in AML-M6 148
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 147
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 145
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 145
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 145
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 145
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 144
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 144
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 144
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 144
Involvement of the urokinase receptor in the cross-talk between hematopoietic stem/progenitor cells and the bone marrow microenvironment. 144
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: preliminary observations. 143
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 143
Impact of cytokine gene polymorphism in aplastic anemia (AA) 143
Effects of leptin and IGF-1 on bone mineral density in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 142
Allogeneic transplantation for multiple myeloma 142
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 141
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 140
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 140
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 140
EFFICACY OF ALEMTUZUMAB PLUS EXTRACORPOREAL PHOTOPHERESIS IN ADVANCED STAGE SEZARY SYNDROME: A CASE REPORT 139
Estrogen-progestin-replacement therapy in women after stem cell transplant 138
miRNA-MEDIATED CO-REGULATION OF UROKINASE RECEPTOR AND CXCR4 EXPRESSION 138
Totale 29.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021866 0 0 0 0 0 0 0 0 0 36 357 473
2021/20222.072 21 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.769 182 250 131 101 144 264 75 93 16 68 105 340
2024/20254.744 165 77 63 149 223 610 880 501 672 253 500 651
2025/202630.141 2.517 6.957 6.325 1.229 1.973 1.104 3.078 579 4.776 1.603 0 0
Totale 57.821